These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27516171)

  • 1. Open data in drug discovery and development: lessons from malaria.
    Wells TN; Willis P; Burrows JN; Hooft van Huijsduijnen R
    Nat Rev Drug Discov; 2016 Oct; 15(10):661-2. PubMed ID: 27516171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malaria medicines: a glass half full?
    Wells TN; Hooft van Huijsduijnen R; Van Voorhis WC
    Nat Rev Drug Discov; 2015 Jun; 14(6):424-42. PubMed ID: 26000721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partnering to fight malaria in India: Past, present and future.
    Samby K; Ramachandruni H; Banerji J; Burrows JN; Daumerie PG; Hooft van Huijsduijnen RAM; Duparc S; Wells TNC
    J Vector Borne Dis; 2019; 56(1):15-24. PubMed ID: 31070161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hits, leads and drugs against malaria through diversity-oriented synthesis.
    Dandapani S; Comer E; Duvall JR; Munoz B
    Future Med Chem; 2012 Dec; 4(18):2279-94. PubMed ID: 23234551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in antimalarial drug discovery.
    Burrows JN; Leroy D; Lotharius J; Waterson D
    Future Med Chem; 2011 Sep; 3(11):1401-12. PubMed ID: 21879844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive review on various strategies for antimalarial drug discovery.
    Mishra M; Mishra VK; Kashaw V; Iyer AK; Kashaw SK
    Eur J Med Chem; 2017 Jan; 125():1300-1320. PubMed ID: 27886547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimalarial drug discovery: recent progress and future directions.
    Calderón F; Wilson DM; Gamo FJ
    Prog Med Chem; 2013; 52():97-151. PubMed ID: 23384667
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening the Medicines for Malaria Venture Pathogen Box across Multiple Pathogens Reclassifies Starting Points for Open-Source Drug Discovery.
    Duffy S; Sykes ML; Jones AJ; Shelper TB; Simpson M; Lang R; Poulsen SA; Sleebs BE; Avery VM
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data-driven medicinal chemistry in the era of big data.
    Lusher SJ; McGuire R; van Schaik RC; Nicholson CD; de Vlieg J
    Drug Discov Today; 2014 Jul; 19(7):859-68. PubMed ID: 24361338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resisting resistance: is there a solution for malaria?
    Verlinden BK; Louw A; Birkholtz LM
    Expert Opin Drug Discov; 2016; 11(4):395-406. PubMed ID: 26926843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in anti-malarial target candidate and product profiles.
    Burrows JN; Duparc S; Gutteridge WE; Hooft van Huijsduijnen R; Kaszubska W; Macintyre F; Mazzuri S; Möhrle JJ; Wells TNC
    Malar J; 2017 Jan; 16(1):26. PubMed ID: 28086874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current drug development portfolio for antimalarial therapies.
    Biagini GA; O'Neill PM; Bray PG; Ward SA
    Curr Opin Pharmacol; 2005 Oct; 5(5):473-8. PubMed ID: 16084770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing the next generation of medicines for malaria control and eradication.
    Burrows JN; van Huijsduijnen RH; Möhrle JJ; Oeuvray C; Wells TN
    Malar J; 2013 Jun; 12():187. PubMed ID: 23742293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the biology component of the drug discovery strategy for malaria eradication.
    Leroy D; Campo B; Ding XC; Burrows JN; Cherbuin S
    Trends Parasitol; 2014 Oct; 30(10):478-90. PubMed ID: 25131411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotransformation and biocatalysis: roles and applications in the discovery of antimalarials.
    Chigorimbo-Murefu NT; Njoroge M; Nzila A; Louw S; Masimirembwa C; Chibale K
    Future Med Chem; 2012 Dec; 4(18):2325-36. PubMed ID: 23234554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges facing drug development for malaria.
    Craft JC
    Curr Opin Microbiol; 2008 Oct; 11(5):428-33. PubMed ID: 18824124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drugs against malaria: What's in the pipeline? Little new in the fight against malaria].
    Schlitzer M
    Pharm Unserer Zeit; 2009; 38(6):522-6. PubMed ID: 19862720
    [No Abstract]   [Full Text] [Related]  

  • 18. Feeding the antimalarial pipeline.
    Schlitzer M; Ortmann R
    ChemMedChem; 2010 Nov; 5(11):1837-40. PubMed ID: 20922746
    [No Abstract]   [Full Text] [Related]  

  • 19. From hybrid compounds to targeted drug delivery in antimalarial therapy.
    Oliveira R; Miranda D; Magalhães J; Capela R; Perry MJ; O'Neill PM; Moreira R; Lopes F
    Bioorg Med Chem; 2015 Aug; 23(16):5120-30. PubMed ID: 25913864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging drugs for malaria.
    Tschan S; Kremsner PG; Mordmüller B
    Expert Opin Emerg Drugs; 2012 Sep; 17(3):319-33. PubMed ID: 22808912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.